Concepedia

Changqing Su

CS

Statistics

Publications

57

Citations

2.1K

H-Index

28

Active since

2004

Affiliations

Eastern Hepatobiliary Surgery Hospital(Current)

Second Military Medical University

Xuzhou Medical College

Changhai Hospital

Chinese Academy of Sciences

Changqing Su is an author at Eastern Hepatobiliary Surgery Hospital specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2004–2024

57

Publications

57

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways

Longlong Bao, Yan Yan, Can Xu et al. · Cancer Letters · 2013 · 181 citations

, , +16

Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway

Zhangxiao Peng, Yan Wang, Jianhui Fan et al. · Scientific Reports · 2017 · 96 citations · Full text

, , +17

Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells

Qin Zhang, Hai Huang, Ao Liu et al. · EBioMedicine · 2019 · 86 citations · Full text

, , +17

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma

Lu Cao, Chunguang Li, Shuwen Shen et al. · BMC Cancer · 2013 · 85 citations · Full text

, , +17

Downregulation of HtrA1 Promotes Resistance to Anoikis and Peritoneal Dissemination of Ovarian Cancer Cells

Xiaoping He, Takayo Ota, Peng Liu et al. · Cancer Research · 2010 · 85 citations · Full text

, , +17

1–5 of 57